GLOBAL VETERINARY VACCINES MARKET 2022-2028

 

 

TABLE OF CONTENTS

 

1.     GLOBAL VETERINARY VACCINES MARKET – SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE VETERINARY VACCINES MARKET

2.2. KEY INSIGHTS

2.2.1.    INCREASING INNOVATION BY MARKET PARTICIPANTS

2.2.2.    ADVANCEMENTS IN VACCINE AND DIAGNOSTIC TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VALUE CHAIN ANALYSIS

2.6. KEY BUYING CRITERIA

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY MARKET STRATEGIES

2.9.1.    MERGERS & ACQUISITIONS

2.9.2.    CONTRACTS & AGREEMENTS

2.9.3.    PRODUCT LAUNCHES

2.9.4.    EXPANSIONS & DIVESTITURES

2.10.               MARKET DRIVERS

2.10.1.                    HIGH VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES

2.10.2.                    GOVERNMENT-ORGANIZED VACCINATION DRIVES  

2.10.3.                    ADVANCED VACCINE RESEARCH AND DEVELOPMENT

2.11.               MARKET CHALLENGES

2.11.1.                    LACK OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS

2.11.2.                    STRINGENT RULES AND REGULATIONS PERTAINING TO VACCINE USE

2.12.               MARKET OPPORTUNITIES

2.12.1.                    GROWING USE OF VACCINES IN THE AMERICAN AND EUROPEAN MARKETS

2.12.2.                    EXPANSION OF THE ANIMAL HEALTHCARE MARKET IN THE ASIA-PACIFIC

2.12.3.                    RISING DEMAND FOR COMPANION ANIMALS

3.     GLOBAL VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE

3.1. LIVESTOCK ANIMALS

3.1.1.    CATTLE

3.1.2.    PIGS

3.1.3.    POULTRY

3.1.4.    SHEEP

3.1.5.    OTHER LIVESTOCK ANIMALS

3.2. COMPANION ANIMALS

3.2.1.    CANINE

3.2.2.    FELINE

3.2.3.    EQUINE

3.3. AQUACULTURE

4.     GLOBAL VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE

4.1. CANINE DISEASE

4.2. PORCINE DISEASE

4.3. BOVINE DISEASE

4.4. POULTRY DISEASE

4.5. AQUACULTURE DISEASE

4.6. OTHER DISEASE TYPES

5.     GLOBAL VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE

5.1. ATTENUATED VACCINES

5.2. INACTIVATED VACCINES

5.3. TOXOID VACCINES

5.4. CONJUGATE VACCINES

5.5. DNA VACCINES

5.6. RECOMBINANT VACCINES

5.7. SUBUNIT VACCINES

6.     GLOBAL VETERINARY VACCINES MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.    MARKET BY ANIMAL TYPE

6.1.1.1.        MARKET BY LIVESTOCK ANIMAL

6.1.1.2.        MARKET BY COMPANION ANIMAL

6.1.2.    MARKET BY DISEASE TYPE

6.1.3.    MARKET BY PRODUCT TYPE

6.1.4.    COUNTRY ANALYSIS

6.1.4.1.        UNITED STATES

6.1.4.2.        CANADA

6.2. EUROPE

6.2.1.    MARKET BY ANIMAL TYPE

6.2.1.1.        MARKET BY LIVESTOCK ANIMAL

6.2.1.2.        MARKET BY COMPANION ANIMAL

6.2.2.    MARKET BY DISEASE TYPE

6.2.3.    MARKET BY PRODUCT TYPE

6.2.4.    COUNTRY ANALYSIS

6.2.4.1.        UNITED KINGDOM

6.2.4.2.        GERMANY

6.2.4.3.        FRANCE

6.2.4.4.        SPAIN

6.2.4.5.        ITALY

6.2.4.6.        REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.    MARKET BY ANIMAL TYPE

6.3.1.1.        MARKET BY LIVESTOCK ANIMAL

6.3.1.2.        MARKET BY COMPANION ANIMAL

6.3.2.    MARKET BY DISEASE TYPE

6.3.3.    MARKET BY PRODUCT TYPE

6.3.4.    COUNTRY ANALYSIS

6.3.4.1.        CHINA

6.3.4.2.        JAPAN

6.3.4.3.        INDIA

6.3.4.4.        SOUTH KOREA

6.3.4.5.        ASEAN COUNTRIES

6.3.4.6.        AUSTRALIA & NEW ZEALAND

6.3.4.7.        REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.    MARKET BY ANIMAL TYPE

6.4.1.1.        MARKET BY LIVESTOCK ANIMAL

6.4.1.2.        MARKET BY COMPANION ANIMAL

6.4.2.    MARKET BY DISEASE TYPE

6.4.3.    MARKET BY PRODUCT TYPE

6.4.4.    COUNTRY ANALYSIS

6.4.4.1.        BRAZIL

6.4.4.2.        MEXICO

6.4.4.3.        ARGENTINA

6.4.4.4.        REST OF LATIN AMERICA

7.     COMPETITIVE LANDSCAPE

7.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH

7.2. BRILLIANT BIO PHARMA

7.3. CEVA SANTE ANIMALE

7.4. ELANCO ANIMAL HEALTH INC

7.5. HESTER BIOSCIENCES LTD

7.6. HIPRA

7.7. INDIAN IMMUNOLOGICALS LIMITED

7.8. MERCK ANIMAL HEALTH

7.9. PHIBRO ANIMAL HEALTH

7.10.               VAXXINOVA GMBH

7.11.               VIRBAC SA

7.12.               ZOETIS INC

8.     RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

 

 

 

TABLE LIST

TABLE 1: GLOBAL VETERINARY VACCINES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: VENDOR SCORECARD

TABLE 4: GLOBAL VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 6: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 7: GLOBAL VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 8: GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 9: GLOBAL VETERINARY VACCINES MARKET, BY GEOGRAPHY, 2022-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 16: EUROPE VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 17: EUROPE VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 18: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 19: EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 20: EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 21: EUROPE VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 22: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 25: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 28: LATIN AMERICA VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 29: LATIN AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

 

 

 

FIGURE LIST

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: VALUE CHAIN ANALYSIS

FIGURE 3: KEY BUYING CRITERIA

FIGURE 4: GLOBAL VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)

FIGURE 5: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 6: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)

FIGURE 7: GLOBAL VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)

FIGURE 8: GLOBAL VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)

FIGURE 9: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)

FIGURE 10: GLOBAL VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)

FIGURE 11: GLOBAL VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 12: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 13: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)

FIGURE 14: GLOBAL VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)

FIGURE 15: GLOBAL VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)

FIGURE 16: GLOBAL VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)

FIGURE 17: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)

FIGURE 18: GLOBAL VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)

FIGURE 19: GLOBAL VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 20: GLOBAL VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: GLOBAL VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 22: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 23: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 24: GLOBAL VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)

FIGURE 25: GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 26: GLOBAL VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 27: GLOBAL VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 28: GLOBAL VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 29: GLOBAL VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 30: GLOBAL VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 31: GLOBAL VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 32: GLOBAL VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 33: GLOBAL VETERINARY VACCINES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)

FIGURE 34: UNITED STATES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: CANADA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: UNITED KINGDOM VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 37: GERMANY VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 38: FRANCE VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 39: SPAIN VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 40: ITALY VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 41: REST OF EUROPE VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 42: CHINA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 43: JAPAN VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 44: INDIA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 45: SOUTH KOREA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 46: ASEAN COUNTRIES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 48: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 49: BRAZIL VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 50: MEXICO VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 51: ARGENTINA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 52: REST OF LATIN AMERICA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

Triton Market Research’s report signifies that the global veterinary vaccines market would register growth at a CAGR of 7.46% over the forecasted years 2022-2028.

The market’s growth is augmented due to factors such as the rise in the animal population & diseases and advancements in vaccines. Moreover, an increase in the demand for companion animals and the expansion of the animal healthcare market also boost its growth.

Meanwhile, the lack of awareness, stringent legalities for vaccine use, and unavailability of skilled veterinarians impede the market’s development process. On the contrary, the market is presented with fruitful opportunities such as expanding the animal healthcare market in Asia-Pacific, rising demand for companion animals, and the growing use of vaccines in the American and European markets.

 

Get more Insights into the Global Veterinary Vaccines Market:

 

https://www.tritonmarketresearch.com/reports/veterinary-vaccines-market

 

REGIONAL OUTLOOK

The global veterinary vaccines market encompasses Europe, North America, the Asia-Pacific, and Latin America. 

Globally, the Asia-Pacific is estimated to show the fastest growth in the market over the forecasted years. The leading players in China and Japan focus on providing intensive care to their livestock due to the highest consumption of dairy and meat products. In this regard, the development of robust R&D has increased the production of vaccines, thereby supporting the market’s growth.

On the other hand, North America has presented itself as the leader in the veterinary vaccines market. The US is one of the biggest vaccine producers for companion animals, thus boosting the growth of the market.

 

 

COMPETITIVE OUTLOOK

The top players governing the veterinary vaccines market include Elanco Animal Health Inc, Virbac SA, Zoetis Inc, Phibro Animal Health, Merck Animal Health, Brilliant Bio Pharma, Hipra, Boehringer Ingelheim International GmbH, Indian Immunologicals Limited, Ceva Sante Animale, Vaxxinova GmbH, and Hester Biosciences Ltd.

Brilliant Bio Pharma is an Indian-based animal health company engaged in animal vaccines, formulation, and nutrition. The company exports its products to more than 30 countries. Additionally, it uses the world’s most advanced vaccine manufacturing system, including bacterial fermentation, freeze-drying, cell propagation, virus culture, plant automation, etc. Rabac VET and FUTVAC are the main selling products in its animal vaccines range.

 

 

SEGMENTATION

1.     BOEHRINGER INGELHEIM INTERNATIONAL GMBH

2.     BRILLIANT BIO PHARMA

3.     CEVA SANTE ANIMALE

4.     ELANCO ANIMAL HEALTH INC

5.     HESTER BIOSCIENCES LTD

6.     HIPRA

7.     INDIAN IMMUNOLOGICALS LIMITED

8.     MERCK ANIMAL HEALTH

9.     PHIBRO ANIMAL HEALTH

10. VAXXINOVA GMBH

11. VIRBAC SA

12. ZOETIS INC